| 标题 |
Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Meletios Α. Dimopoulos; Meral Beksaç; Luděk Pour; Sosana Delimpasi; Vladimir Vorobyev; et al 出版日期:2025-11-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)